Keyword: Divi's Laboratories
Sun Pharma chief Dilip Shanghvi snared only $3,690 in 2018 pay—including a 1.5-cent salary—as investors questioned its management practices.
Here's your pharma manufacturing news of note.
Samsung won FDA nod for a Remicade biosim, Otsuka expanded anemia deal with Akebia, analysts are cautiously optimistic about China's foreign drug proposal.
The FDA, which banned APIs coming from a Divi’s plant in India, has followed that with a warning letter that savages the facility for a lack of data integrity.